BACKGROUND: Polypharmacy and potential drug-drug interactions (pDDIs) are major challenges in the management of elderly patients with multiple comorbidities, often leading to adverse drug events and increased healthcare burden. AIM: This study aimed to determine the prevalence and patterns of polypharmacy and pDDIs among elderly patients attending Yenepoya Medical College and Hospital, Mangalore, India. METHODS: A cross-sectional study was conducted from January to June 2023 among 310 elderly patients (aged ≥60 years) selected through simple random sampling from both in-patient and out-patient departments. Polypharmacy was defined as the concurrent use of ≥5 medications, and excessive polypharmacy as ≥9 medications. Drug interaction screening was performed using UpToDate and Medscape interaction checker tools. Statistical analyses included descriptive statistics, t-tests, chi-square tests, and regression analysis, with significance set at p < 0.05. RESULTS: The prevalence of polypharmacy was slightly higher in females (53.84%) than males (51.94%), with the highest rates observed in the 70-79 age group (48.88%). Most patients experienced moderate (50%) drug interactions. A significant gender difference was observed in the number of drugs prescribed at treatment (p = 0.0032), but not at discharge. Regression analysis identified gender (p = 0.018) and inpatient status (p < 0.001) as significant predictors of polypharmacy, while age was not (p = 0.719). CONCLUSION: This study reveals a high prevalence of polypharmacy among elderly patients attending Yenepoya Medical College and Hospital. Polypharmacy was found to be more prevalent among female patients, older age groups, and in inpatient wards. The distribution of drug interactions revealed a pervasive nature across various degrees, with moderate interactions being the most common. Future research should use larger samples, and diverse populations to better understand polypharmacy, drug interactions, and outcomes.
Knee osteoarthritis (OA) is a popular and progressive degenerate joint disease and require a predictor of risk at the primary stage to predict drug treatment and propose an early intervention. The current methods of deep learning are not sufficient enough to deal with integrating the heterogeneous modality component, modeling of irregular temporal follow ups, and capture of the fine grained variations of pathological types. In order to address such limitations, this paper suggests a new multimodal approach named, RAD-OAEnsemble which introduces three main innovations. First, a novel Cross Bi-modal Heterogeneous Graph Fusion Network (CBHGF-Net) is introduced for the multi-scale semantic fusion of Radiographs and Electronic Health Records (EHRs). Second, a Modified DenseNet with Multi-scale Attention Criss-Cross Blocks (MACC-Blocks) is presented to extract the anatomical features of knee OA patterns by utilizing dilated convolution, criss-cross attention, residual attention gating. Third, a Dual-Stream Tranfo-Convo (DTC) Deep Temporal Embedding module is proposed that consists of a Time-Warped Convolutional Blocks and a Temporal Decay Encoded Informer for the knee OA risk prediction. The suggested approach delivered better outcomes with accuracy of 99.275%, precision of 98.175%, specificity of 99.165%, sensitivity of 98.95%, and F1-score of 98.175% in having considerably a low rate of false positives (1.875%) and false negatives (2.175%). The findings support the relevance of the suggested framework in providing resilient, time-sensitive, and explainable OA progression predictions by multimodal combination and high-fidelity feature learning.
Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition, contributing significantly to global morbidity and mortality. Traditional diagnostic tools are effective in diagnosing COPD. However, these tools demand specialized equipment and expertise. Advances in artificial intelligence (AI) provide a platform for enhancing COPD diagnosis by leveraging diverse data modalities. The existing reviews primarily focus on single modalities and lack information on interpretability and explainability. Thus, this review intends to synthesize the AI-powered frameworks for COPD identification, focusing on data modalities, methodological innovation, evaluation strategies, and reporting limitations and potential biases. By adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a systematic search was conducted across multiple repositories. From an initial pool of 1978 records, 22 studies were included in this review. The included studies demonstrated exceptional performance in specific settings. Most studies were retrospective and limited in diversity, lacking generalizability and external or prospective validation. This review presents a roadmap for advancing AI-assisted COPD detection. By highlighting the strengths and limitations of existing studies, it supports the development of future research. Future studies can utilize the findings to build models using prospective, multicenter, and multi-ethnic validations, ensuring generalizability and fairness.
BACKGROUND: Down syndrome (DS) is one of the most prevalent chromosomal abnormalities affecting global healthcare. Recent advances in artificial intelligence (AI) and machine learning (ML) have enhanced DS diagnostic accuracy. However, there is a lack of thorough evaluations analyzing the overall impact and effectiveness of AI-based DS diagnostic approaches. OBJECTIVES: This review intends to identify methodologies and technologies used in AI-driven DS diagnostics. It evaluates the performance of AI models in terms of standard evaluation metrics, highlighting their strengths and limitations. METHODOLOGY: In order to ensure transparency and rigor, the authors followed the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. They extracted 1175 articles from major academic databases. By leveraging inclusion and exclusion criteria, a final set of 25 articles was selected. OUTCOMES: The findings revealed significant advancements in AI-powered DS diagnostics across diverse data modalities. The modalities, including facial images, ultrasound scans, and genetic data, demonstrated strong potential for early DS diagnosis. Despite these advancements, this review outlined the limitations of AI approaches. Small and imbalanced datasets reduce the generalizability of the AI models. The authors present actionable strategies to enhance the clinical adoptions of these models.
Down syndromeartificial intelligencemachine learningprenatal diagnosis
Down syndrome (DS) is one of the prevalent chromosomal disorders, representing distinctive craniofacial features and a range of developmental and medical challenges. Due to the lack of clinical expertise and high infrastructure costs, access to genetic testing is restricted to resource-constrained clinical settings. There is a demand for developing a non-invasive and equitable DS screening tool, facilitating DS diagnosis for a wide range of populations. In this study, we develop and validate a robust, interpretable deep learning model for the early detection of DS using facial images of infants. A hybrid feature extraction architecture combining RegNet X-MobileNet V3 and vision transformer (ViT)-Linformer is developed for effective feature representation. We use an adaptive attention-based feature fusion to enhance the proposed model's focus on diagnostically relevant facial regions. Bayesian optimization with hyperband (BOHB) fine-tuned extremely randomized trees (ExtraTrees) is employed to classify the features. To ensure the model's generalizability, stratified five-fold cross-validation is performed. Compared to the recent DS classification approaches, the proposed model demonstrates outstanding performance, achieving an accuracy of 99.10%, precision of 98.80%, recall of 98.87%, F1-score of 98.83%, and specificity of 98.81%, on the unseen data. The findings underscore the strengths of the proposed model as a reliable screening tool to identify DS in the early stages using the facial images. This study paves the foundation to build equitable, scalable, and trustworthy digital solution for effective pediatric care across the globe.
face imagesinfantsnon-invasive screeninghybrid feature extraction
Epilepsy represents a widespread neurological disorder that causes unexpected seizure occurrences which produce significant obstacles for daily life activities in people worldwide. Real-time seizure detection accuracy stands vital for safeguarding patients while ensuring timely interventions and bettering their quality of life. The present seizure detection methods suffer from multiple limitations including poor applicability across different cases and excessive incorrect alerts and inefficient feature selection procedures. Traditional deep learning algorithms generally fail to detect EEG patterns with both temporal and spatial characteristics thereby producing subpar results in practical settings. This study proposes EpilepNet-LD integrated with federated learning (FL), a novel framework for decentralized EEG analysis that preserves patient privacy while enabling collaborative model training. The framework employs a hybrid harmony search and mutual information (HSA-MI) feature selection technique to identify optimal temporal, spectral, and spatial EEG features, reducing computational overhead. The EpilepNet-LD architecture combines long short-term memory (LSTM) networks to capture temporal dependencies with DenseNet-121 to extract hierarchical spatial features, improving seizure detection performance. Extensive experimental evaluations confirmed the proposed method achieves 99.41% extensive experiments demonstrate that the proposed method achieves 99.41% accuracy and 99.50% sensitivity, outperforming existing state-of-the-art approaches. The integrated FL and HSA-MI approach, coupled with the EpilepNet-LD classifier, enables robust, real-time, and high-precision seizure detection, offering a reliable solution for advanced epilepsy monitoring and management.
epilepsyseizure detectionfederated learningmutual information feature selection
Background As a crucial cognitive and motor function, handwriting can reveal dyslexia, dysgraphia, and other neurodevelopmental conditions. With the emergence of AI, deep learning (DL) models can analyze handwriting patterns for early identification and categorization of these conditions with high level of accuracy. Objective This study presents a literature review by examining DL models in classifying learning disabilities using handwriting data. It identifies models’ shortcomings and suggests future research directions, improving model accuracy, fairness, and usability. Methodology By employing the standard literature guidelines, the authors identified 24 studies from a pool of 502 studies. They extracted dataset details, methodologies, and key findings from the studies. Findings The findings indicate the dominance of convolutional neural networks in improving learning disabilities classification through the extraction of fine-grained spatial handwritten patterns. Vision transformers (ViTs) show potential for long-range contextual feature extraction to enhance the model’s generalization capabilities. Despite these advances, dataset size, model generalizability, computational efficiency, interpretability, and real-world deployment continue to be significant challenges. Conclusions The review findings underscore the transformative potential of DL-based handwriting analysis in educational and clinical settings, providing early detection and intervention in learning disabilities.
Abstract This study presents an eco-friendly approach for synthesizing chitosan-coated superparamagnetic iron oxide nanoparticles (Ch-SPIONs) using Carica papaya bark extract as a green reducing and stabilizing agent. The phytochemicals present in the bark extract facilitate the formation of SPIONs with well-defined magnetic characteristics. Comprehensive characterization through UV-visible spectroscopy, X-ray diffraction, scanning and transmission electron microscopy, energy-dispersive X-ray spectroscopy, and Fourier-transform infrared spectroscopy confirmed the successful synthesis of Ch-SPIONs. The nanoparticles exhibited an average size range of 50–80 nm with a rectangular morphology and a UV-vis absorption peak at 300 nm. The antioxidant potential of Ch-SPIONs was evaluated, revealing concentration-dependent scavenging activity that surpassed standard antioxidants at higher concentrations. Antibacterial assays demonstrated significant efficacy against Klebsiella pneumoniae (15 mm inhibition zone) and Staphylococcus aureus (20 mm inhibition zone). Furthermore, in vitro cytotoxicity studies on HeLa cervical cancer cells showed dose-dependent cell death, with an IC 50 value of 18 ± 0.4 μg·mL −1 , compared to 11 ± 0.5 μg·mL −1 for doxorubicin. Apoptotic induction and cell cycle disruption were further validated through fluorescence microscopy and flow cytometry. These findings underscore the potential of Carica papaya -mediated Ch-SPIONs as a sustainable, biocompatible nanomaterial for anticancer and antimicrobial applications, offering a promising alternative to conventional synthesis methods.
green synthesisantioxidant activityantibacterial activityKlebsiella pneumoniae
experiments using a rotenone (ROT) induced PD rat model confirmed that Lf-DA-MSN-PF127 crosses the BBB and delivers dopamine. It remarkably boosts motor symptoms and dopamine levels in ROT-induced PD rats. Our study illustrates the nontoxic effect of the Lf-DA-MSN-PF127 nanocomposite and its efficacy in delivering dopamine across the BBB, providing a novel treatment strategy for PD.
Down syndrome (DS) is a genetic condition characterized by distinct facial features and developmental challenges, making early and accurate detection crucial for timely intervention and support. Traditional diagnostic methods often require specialized expertise, which can be resource intensive and inaccessible in many settings. In this study, we propose a novel artificial intelligence (AI)-driven approach to detecting DS using facial images, leveraging advancements in deep learning and machine learning for accurate and scalable diagnostics. A dataset of 168 facial images was curated from publicly accessible platforms, comprising 95 images of individuals without DS and 73 with the condition. The model was implemented using TensorFlow/PyTorch and employs RegNet X and Shifted Window Transformer (SWIN Transformer) for feature extraction, capturing both local and global facial features. To enhance feature representation, an attention-based fusion mechanism was applied, prioritizing the most discriminative patterns while filtering redundant information. For classification, an Extremely Randomized Tree (ExtraTrees) model was employed, known for its ability to efficiently handle high-dimensional data with strong generalization capabilities. The model was fine-tuned using Bayesian Optimization and Hyperband (BOHB), which optimized hyperparameters by balancing exploration and exploitation, thereby improving predictive performance. The final classification achieved a 99.2% accuracy with an area under the curve (AUC) of 1.00, demonstrating exceptional reliability in distinguishing DS from normal cases. By combining advanced feature extraction, fusion, and classification techniques, this study highlights the potential of AI to revolutionize DS diagnostics, offering a non-invasive, efficient, and scalable solution for early detection.
Down syndromeface classificationearly diagnosismodel interpretability